UiPath stock falls despite strong Q2 growth with $13.07 support in focus

UiPath stock falls despite strong Q2 growth with $13.07 support in focus
UiPath slides 3.17% to $13.78 today

UiPath Inc (PATH) stock is trading at $13.78 after declining 3.17% on the day. The price sits below its key short- and medium-term moving averages, with modest volatility shaping the session.

PATH price prediction
24H -0.6%
$11.66
48H -0.6%
$11.66
7D -1.28%
$11.58
1M -3.5%
$11.32
3M -3.32%
$11.34
6M -32.91%
$7.87
12M -19.01%
$9.5
Current price: $11.73 -0.6700 5.40%
Closed 11/18
Daily range 11.66 Arrow from to Icon 12.39
Weekly range 11.66 Arrow from to Icon 13.44
Loading...

Highlights

  • UiPath reported a 12% year-over-year increase in annual recurring revenue to $1.938 billion and total revenue up 13% to $410 million.
  • The company achieved a non-GAAP operating income of $89 million for the quarter, with GAAP profitability sustained for four consecutive quarters.
  • Shares of UiPath trade below key short- and medium-term moving averages with technical indicators signaling persistent downside pressure and a projected range of $13.07 to $14.49.

Revenue and margin growth offset by continued selling pressure

UiPath Inc reported its second-quarter results, with annual recurring revenue climbing 12% year over year to $1.938 billion and total revenue gaining 13% to $410 million. The company achieved a non-GAAP operating income of $89 million for the period, reflecting a 22% operating margin, while GAAP operating income marked a fourth straight profitable quarter. Cloud annual recurring revenue was up more than 19% to about $1.3 billion, and the number of customers generating over $1 million in annual recurring revenue grew 21% to 387, according to Tipranks, though price action has remained under broader selling pressure.

UiPath Inc. asset chart
UiPath Inc. price dynamics. Source: TradingView.

Bearish momentum holds as oversold readings test support zones

On the technical front, PATH/USD trades below the MA-20 at $14.33 and MA-50 at $14.16 on the hourly chart, while staying above the MA-200 at $12.91 on the daily timeframe. The Ichimoku Kijun sits at $14.34, representing immediate resistance. Momentum and oscillator indicators remain negative: MACD and ADX point to ongoing bearish momentum, while RSI at 37.38 along with Stoch RSI and CCI indicate oversold conditions. Bull/Bear Power highlights seller dominance, and the price is hovering close to the daily low of $13.78, with Awesome Oscillator not confirming a clear new move. This cluster of technical signals affirms persistent downside pressure on the stock.

Downside bias prevails as range-bound trading faces resistance

Over the next several sessions, PATH is likely to remain range-bound between $13.07 and $14.49, with more than 80% probability favoring a downward move and less than 20% likelihood of an upside reversal. The baseline forecast sees price consolidating within this band amid current volatility conditions. A bullish scenario would require a firm break above resistance near $14.34, while a bearish extension could develop should the price fall through support at $13.07.

Anton Kharitonov, expert at Traders Union, sees UiPath's strong fundamentals overshadowed by persistent technical weakness. Despite solid growth in annual recurring revenue and profitable quarters, downward momentum remains dominant. He notes that bearish indicators and resistance near $14.34 limit optimism. "Until PATH breaks convincingly above key resistance, I remain defensively positioned and do not expect a sustained recovery."

Earlier, analysts noted that UiPath shares faced mixed technical signals and near-term consolidation despite strong operational performance and industry recognition. The current technical setup points to increased downside risk, making support at $13.07 a critical level for traders to monitor in the event of further weakness.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.